Clinical Trials Logo

Clinical Trial Summary

250 women will be randomly divided into 2 equal groups using computer generated random numbers. Group 1 will receive Carbetocin 100 µgm (Pabal® Ferring, UK) and group 2 will receive oxytocin 5IU (Syntocinon®, Novartis, Switzerland). Both drugs will be diluted in 10ml saline and will be given by the slowly intravenously after delivery of the anterior shoulder. The investigators will not include a control group for ethical reasons.


Clinical Trial Description

Obstetric haemorrhage remains one of the major causes of maternal death in both developed and developing countries (1). Postpartum haemorrhage (PPH) is defined as a blood loss >500 ml more of blood from the genital tract within 24 hours of the birth of a baby. PPH can be minor (500-1000 ml) or major (more than 1000 ml). The most frequent cause of PPH is uterine atony, contributing up to 80 % of the PPH cases.

Risk factors of atonic PPH include multiple pregnancy, placenta previa, previous PPH, body mass index (BMI) >30, prolonged labour, fetal macrosomia>4kg and primipara> 40 years.

Oxytocin is currently the uterotonic of first choice. It has proven to decrease the incidence of PPH by 40 % and has a rapid onset of action and a good safety profile. A disadvantage of oxytocin is its short half-life of 4-10 min, regularly requiring a continuous intravenous infusion or repeated intramuscular injections.

Carbetocin is a long-acting oxytocin analogue indicated for the prevention of uterine atony after child birth by CS under epidural or spinal anaesthesia. Carbetocin has a rapid onset of action (within 1-2 min) and a prolonged duration of action (approximately 1 h) because of sustained uterine response with contractions of higher amplitude and frequency. Its safety profile is comparable to that of oxytocin.

The study will be conducted in Cairo university hospitals and BeniSuef university hospitals. All patients with at least 2 risk factors for developing atonic PPH will be approached in the antenatal clinic or early in labour if appropriate. Risk factors include previous PPH, BMI>35, multiple pregnancy, prolonged labour >12 hours, fetal macrosomia>4kg and induction of labour. Women will be invited to participate in the study, the invitation will include a clear full explanation of the study. Only patients signing informed written consents will participate in the study.

250 women will be randomly divided into 2 equal groups using computer generated random numbers. Group 1 will receive Carbetocin 100 µgm (Pabal® Ferring, UK) and group 2 will receive oxytocin 5IU (Syntocinon®, Novartis, Switzerland). Both drugs will be diluted in 10ml saline and will be given by the slowly intravenously after delivery of the anterior shoulder. We will not include a control group for ethical reasons.

The uterine tone and amount of bleeding will be noted and the need for further uterotonic agents will be determined 2 minutes after giving the drug. Blood loss will be estimated through weighing the swabs and using pictorial charts. Blood haemoglobin will be assessed 24 hours after delivery. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT02304042
Study type Interventional
Source Cairo University
Contact
Status Completed
Phase Phase 3
Start date November 2014
Completion date July 2015

See also
  Status Clinical Trial Phase
Completed NCT05708482 - Sling and Swing Positions to Pregnant Women N/A
Completed NCT04208867 - Quality Improvement Project for Reproductive Health Services in India, Phase 1 N/A
Completed NCT03407209 - Compared Efficacy of Patient-controlled Epidural Analgesia With or Without Automatic Boluses N/A
Not yet recruiting NCT04160273 - Evaluation of Postpartum Posttraumatic Stress Disorder at Angers University Hospital (ESPT-PP) N/A
Completed NCT03656601 - Tridimensional Pelvic Floor Ultrasound and Quality of Life Scores Questionnaires in Nulliparous or Parous Women
Active, not recruiting NCT01100970 - Cortisol Levels in Infants Born by C-section - Electric Unipolar Needle Versus Electric Bipolar Needle N/A
Completed NCT06036277 - Influence of Immersion in Water During Labor on the Request of Epidural Anesthesia by Pregnant Women
Completed NCT03364517 - Extra Hospital Delivery Outside Medical Presence. N/A
Not yet recruiting NCT03840889 - Secondary Postpartum Hemorrhage
Completed NCT03965026 - Activity Modeling in Birth Room
Terminated NCT02649920 - Comparing the Efficiency of Cervical Ripening BALLoon (Cook) to the DINOprostone (Propess) for the Cervical Maturation in Case of Unfavorable Cervix (Bishop <6) in the Population of Obese Pregnant Women (BMI >= 30 kg/m²) N/A
Completed NCT04897451 - Quality of Life After Cervical Ripening
Completed NCT02474745 - Study of the Type of Pushing at Delivery N/A
Completed NCT02827019 - Newborn in Helathy Birthroom: Assessment of Pratical Home and Mother Lived
Completed NCT04729192 - Translation and Validation of the Turkish Version of the ObsQoR-10 Questionnaire (ObsQoR-10T)
Recruiting NCT04489602 - Translation and Validation of the French Version of the ObsQoR-10 Questionnaire
Completed NCT03953573 - Management of Post-delivery Pain and Its Impact on Resumption of Sexuality
Recruiting NCT06016712 - The Effect of Labor on Intraocular Pressure Fluctuation in Healthy Eyes N/A
Completed NCT04208191 - Quality Improvement Project for Maternal Health and Family Planning Services in Kenya N/A
Completed NCT02976311 - Comparison of Inflammatory Responses Subsequent to Different Cesarean Section Techniques N/A